The global orthobiologics market is anticipated to grow at a compound annual growth rate of 7.03 percent between 2016 and 2020.
Here are five points:
1. An increase in funding to advance orthobiologics will spur market growth.
2. Many vendors are investing in research for new product development.
3. Strategic marketing partnerships will also drive market growth.
4. Spinal fusion costliness will hinder orthobiologics' sales.
5. Key market players include DePuy Synthes, Medtronic, Sanofi, Stryker and Zimmer Biomet.